A comprehensive view of United Therapeutics Corp.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
UNITED THERAPEUTICS CORP - (8-K) - Disclosing Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
Published:
March 25, 2024
by SEC Edgar Filings
|
'Treprostinil Prodrugs' in Patent Application Approval Process (USPTO 20240051979)
Published:
March 05, 2024
by NewsRx Cardiovascular Daily
|
United Therapeutics Corp. Files SEC Form 10-K, Annual Report [Section 13 And 15(D), Not S-k Item 405]: (Feb. 21, 2024)
Published:
March 01, 2024
by NewsRx Pharma Business Daily
|
United Therapeutics Corporation - Material Event - Form 8-K
Published:
February 27, 2024
by U.S. Markets (Alternative Disclosure) via PUBT
|
UNITED THERAPEUTICS CORP - (8-K) - Disclosing Other Events
Published:
February 27, 2024
by SEC Edgar Filings
|
Ask us about our Health Care Sector market view